Unichem reports 97.6% export contribution in FY26
Unichem Laboratories disclosed that exports constituted 97.6% of its total turnover in FY26, according to its Business Responsibility and Sustainability Report. The company reported significant environmental metrics, including a 26% reduction in Scope 1 and Scope 2 emissions and the recycling of 84% of treated effluent. Additionally, the document details workforce statistics, governance structures, and the settlement of a patent dispute with the EU Commission.
*this image is generated using AI for illustrative purposes only.
Unichem Laboratories reported that exports contributed 97.6% to its total turnover during the financial year 2025-26. The pharmaceutical manufacturer, which operates on a standalone basis, disclosed this figure in its Business Responsibility and Sustainability Report for FY26. The company’s operations are primarily focused on the manufacture and sale of pharmaceutical products, specifically allopathic medicines, which accounted for 100% of its turnover.
The company detailed its operational footprint, noting it maintains six plants and one research and development center nationally, alongside five international offices. Unichem serves 14 states within India and exports to 65 countries. Its paid-up capital stands at ₹ 14.08 crores. The report highlights that the company’s products cater to diverse therapeutic areas including cardiology, gastroenterology, and diabetology.
Environmental Performance
Unichem outlined its progress against specific environmental commitments. The company recycled 84% of its treated effluent, surpassing its target, and managed 53% of total waste through co-processing, reuse, or recycling. It reported a 26% reduction in Scope 1 and Scope 2 emissions against the baseline year. Furthermore, the company achieved an 18.1% year-on-year reduction in Accident Frequency Rate (AFR) and Incident Frequency Rate (IFR).
Zero liquid discharge is implemented at manufacturing plants located in Goa, Roha, Pithampur, and Kolhapur. The total energy consumed during the year was 6,43,799 Giga Joules, with energy intensity per rupee of turnover recorded at 45.59. Water consumption totalled 4,87,500 kilolitres, with a water intensity per rupee of turnover of 34.52.
Workforce and Governance
The company’s workforce data as of the end of FY26 shows a total of 2,815 individuals, including 1,907 employees and 908 workers. Women comprised 13.90% of the total employee workforce and 0.11% of the total worker workforce. The Board of Directors includes one female member out of six, representing 16.67%.
| Category | Total | Male | Female |
|---|---|---|---|
| Total Employees | 1,907 | 1,642 | 265 |
| Total Workers | 908 | 907 | 1 |
Regarding governance, the Board is responsible for decision-making on sustainability-related issues. The company reported that it had paid an amount of Euro 16,753,873.4 against an EU Commission demand notice relating to a Perindopril patent dispute from 2005. No instances of data breaches or product recalls due to safety issues involving forced recalls were reported during the year, though three voluntary recalls occurred due to mislabelling and impurity specifications.
Historical Stock Returns for Unichem Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.15% | +2.36% | +24.36% | +6.68% | -20.77% | +41.59% |
How will the recent settlement of the EU Commission patent dispute impact Unichem's future pricing strategy and market access in Europe?
Given the high export dependency of 97.6%, what measures is Unichem taking to mitigate risks associated with global regulatory changes or currency fluctuations?
Will Unichem invest in further R&D to diversify its therapeutic portfolio beyond cardiology, gastroenterology, and diabetology to sustain growth?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
